26th Nov 2025 Plain language summary: real-world tafamidis study in transthyretin amyloid cardiomyopathy (ATTR-CM) patients
20th Jun 2025 Plain language summary: how aficamten performed in the SEQUOIA-HCM trial for patients with symptomatic obstructive hypertrophic cardiomyopathy
27th May 2025 How tafamidis affects lifespan in people with transthyretin amyloid heart disease: plain language summary
20th May 2025 Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary
23rd Sep 2024 Impact of extended tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM)
